{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:57:20Z","timestamp":1788494240646,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ejmech.2019.111789","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T19:22:16Z","timestamp":1571426536000},"page":"111789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Design, synthesis and biological evaluation of suramin-derived dual antagonists of the proinflammatory G protein-coupled receptors P2Y2 and GPR17"],"prefix":"10.1016","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5575-8896","authenticated-orcid":false,"given":"Thanigaimalai","family":"Pillaiyar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Funke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haneen","family":"Al-Hroub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Weyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliaa","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-6624","authenticated-orcid":false,"given":"Christa E.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111789_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1517\/17460441.2013.744746","article-title":"Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders","volume":"8","author":"Geldenhuys","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.111789_bib2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fchem.2018.00206","article-title":"Probing substituents in the 1- and 3-position: tetrahydropyrazino-annelated water-soluble xanthine derivatives as multi-target drugs with potent adenosine receptor antagonistic activity","volume":"6","author":"Koch","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2019.111789_bib3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0026-895X(25)09210-7","article-title":"Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor","volume":"50","author":"Nicholas","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111789_bib4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bcp.2005.11.010","article-title":"Structure activity and molecular modeling analyses of ribose- and base-modified uridine 5\u2032-triphosphate analogues at the human P2Y2 and P2Y4 receptors","volume":"71","author":"Jacobson","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111789_bib5","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1021\/jm801442p","article-title":"Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling","volume":"52","author":"Hillmann","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111789_bib6","doi-asserted-by":"crossref","first-page":"10151","DOI":"10.1074\/jbc.272.15.10151","article-title":"The P2U purinoceptor obligatorily engages the heterotrimeric G protein G16 to mobilize intracellular Ca2+ in human erythroleukemia cells","volume":"272","author":"Baltensperger","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111789_bib7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s40265-015-0409-7","article-title":"Diquafosol ophthalmic solution 3%: a review of its use in dry eye","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2019.111789_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/SHK.0b013e318160dad4","article-title":"A3 and P2Y2 receptors control the recruitment of neutrophils to the lungs in a mouse model of sepsis","volume":"30","author":"Inoue","year":"2008","journal-title":"Shock"},{"key":"10.1016\/j.ejmech.2019.111789_bib9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V100.3.925","article-title":"Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2Y receptors","volume":"100","author":"Idzko","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2019.111789_bib10","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.4049\/jimmunol.181.3.2181","article-title":"Activation of human alveolar macrophages via P2 receptors: coupling to intracellular Ca2+ increases and cytokine secretion","volume":"181","author":"Myrtek","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2019.111789_bib11","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1398-9995.2010.02426.x","article-title":"The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation","volume":"65","author":"M\u00fcller","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.ejmech.2019.111789_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11302-017-9589-9","article-title":"Myeloid P2Y2 receptor promotes acute inflammation but is dispensable for chronic high-fat diet-induced metabolic dysfunction","volume":"14","author":"Adamson","year":"2018","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.ejmech.2019.111789_bib13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4049\/jimmunol.0904042","article-title":"Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema","volume":"185","author":"Cicko","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2019.111789_bib14","doi-asserted-by":"crossref","first-page":"35962","DOI":"10.18632\/oncotarget.16414","article-title":"The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease","volume":"8","author":"M\u00fcller","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2019.111789_bib15","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/ATVBAHA.115.307397","article-title":"Extracellular ATP induces vascular inflammation and atherosclerosis via purinergic receptor Y2 in Mice","volume":"36","author":"Stachon","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejmech.2019.111789_bib16","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1021\/acs.jmedchem.7b00854","article-title":"Molecular recognition of agonists and antagonists by the nucleotide-activated G protein-coupled P2Y2 receptor","volume":"60","author":"Rafehi","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111789_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bmcl.2007.10.082","article-title":"Combinatorial synthesis of anilinoanthraquinone derivatives and evaluation as non-nucleotide-derived P2Y2 receptor antagonists","volume":"18","author":"Weyler","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111789_bib18","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1016\/j.bmcl.2017.09.043","article-title":"From UTP to AR-C118925, the discovery of a potent non nucleotide antagonist of the P2Y2 receptor","volume":"27","author":"Kindon","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111789_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11302-016-9542-3","article-title":"Synthesis, characterization, and in\u00a0vitro evaluation of the selective P2Y2 receptor antagonist AR-C118925","volume":"13","author":"Rafehi","year":"2017","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.ejmech.2019.111789_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/092986706775476052","article-title":"P2 receptors activated by uracil nucleotides - an update","volume":"13","author":"Brunschweiger","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111789_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0074-7696(04)40002-3","article-title":"Cellular distribution and functions of P2 receptor subtypes in different systems","volume":"240","author":"Burnstock","year":"2004","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.ejmech.2019.111789_bib22","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1124\/mol.63.6.1256","article-title":"The G-protein coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints","volume":"63","author":"Fredriksson","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111789_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004350","article-title":"Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonist","volume":"6","author":"Hennen","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejmech.2019.111789_bib24","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1038\/sj.emboj.7601341","article-title":"The orphan receptor GPR17 identified as a new dual uracil nucleotides\/cysteinyl-leukotrienes receptor","volume":"25","author":"Ciana","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2019.111789_bib25","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1046\/j.1471-4159.1998.70041357.x","article-title":"A\u00a0novel orphan G protein-coupled receptor primarily expressed in the brain is localized on human chromosomal band 2q21","volume":"70","author":"Bl\u00e4sius","year":"1998","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2019.111789_bib26","doi-asserted-by":"crossref","first-page":"e3579","DOI":"10.1371\/journal.pone.0003579","article-title":"The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair","volume":"3","author":"Lecca","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.111789_bib27","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nn.2410","article-title":"The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination","volume":"11","author":"Chen","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2019.111789_bib28","doi-asserted-by":"crossref","first-page":"10593","DOI":"10.1074\/jbc.M110.162867","article-title":"Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation","volume":"286","author":"Fumagalli","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111789_bib29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1124\/mol.116.107904","article-title":"The orphan receptor GPR17 is unresponsive to uracil nucleotides and cysteinyl leukotrienes","volume":"91","author":"Simon","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111789_bib30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.chembiol.2018.03.012","article-title":"Repurposing HAMI3379 to block GPR17 and promote rodent and human oligodendrocyte differentiation","volume":"25","author":"Merten","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2019.111789_bib31","doi-asserted-by":"crossref","first-page":"8136","DOI":"10.1021\/acs.jmedchem.7b01768","article-title":"3-(2-Carboxyethyl)indole-2-carboxylic acid derivatives: structural requirements and properties of potent agonists of the orphan g protein-coupled receptor GPR17","volume":"61","author":"Baqi","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111789_bib32","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1021\/jo00218a019","article-title":"Catalysis of sulfonate ester hydrolysis by an intramolecular amide group assistance","volume":"50","author":"Thea","year":"1985","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111789_bib33","first-page":"665","article-title":"P2Y receptors: biological advances and therapeutic opportunities","volume":"4","author":"Shaver","year":"2001","journal-title":"Curr. Opin. Drug Discov. Dev"},{"key":"10.1016\/j.ejmech.2019.111789_bib34","first-page":"3","article-title":"Pharmacological characterization of P2 (nucleotide) receptors","volume":"16","author":"Jacobson","year":"2000","journal-title":"Cell Transm."},{"key":"10.1016\/j.ejmech.2019.111789_bib35","series-title":"P2Y2 Receptors and Other Pyrimidergic P2Y Receptor Subtypes: Functional Characterization, Cloning and Search for Selective Ligands","author":"Kaulich","year":"2003"},{"key":"10.1016\/j.ejmech.2019.111789_bib36","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1021\/acs.jmedchem.8b00147","article-title":"Nitro-group-containing drugs","volume":"62","author":"Nepali","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111789_bib37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/5584_2017_92","article-title":"Pharmacological properties and biological functions of the GPR17 receptor, a potential target for neuro-regenerative medicine","volume":"1051","author":"Fumagalli","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2019.111789_bib38","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1021\/jm0310030","article-title":"Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability","volume":"47","author":"Yan","year":"2004","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419309419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419309419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:05:15Z","timestamp":1759327515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419309419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":38,"alternative-id":["S0223523419309419"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111789","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of suramin-derived dual antagonists of the proinflammatory G protein-coupled receptors P2Y2 and GPR17","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111789"}}